[Specific immunotherapy in metastasizing breast cancer combined with chemotherapy. A prospective randomized study].
40 patients with metastasized mamma carcinoma were immunized with T-antigen, in addition to cytostatic therapy. A second group of 40 patients received cytostatics only. No improvement of remission rates could be obtained by additional immunotherapy with T-antigen.
D000951:Antigens, Neoplasm / Q000276:immunology*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000276:immunology / Q000628:therapy; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D011379:Prognosis; D011446:Prospective Studies; D011897:Random Allocation
D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents
Spezifische Immuntherapie beim metastasierenden Mammakarzinom kombiniert mit Chemotherapie. Eine prospektiv randomisierte Studie.